Fresneau et al. [29] investigated AFP decline in 179 patients with non-seminomatous GCT, aged ≤ 18 years, and they reported that the risk of progression or relapse is marginally increased with a small AFP decline during the first 21 days. The gene discussed is AFP; the disease is granular cell tumor.